www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the

analysis For 3 months period & For 9 months period Performance for the 3rd quarter of 2019 For 3 months period ended of September 30th, 2019 Consolidated Profit & Loss of Global Consumer Public Company

INDORAMA VENTURES PUBLIC COMPANY LIMITED 75/102 Ocean Tower 2, 37th Floor, Asoke Road, Klongtoey Nuer, Wattana, Bangkok 10110, Thailand Tel. 02-661-6661 Fax. 02-661-6664 www.indoramaventures.com 1

วันที่ 15 ตุลาคม 2545 1 NO. (SUTHA-SET) 010/2019/EN 15 May 2019 Subject: Management Discussion and Analysis of the Company and its subsidiary for period ended 31 March 2019 To: The President of the

(THIS REPORT DISCUSSES PRINCIPAL CHANGES ON THE UNREVIEWED CONSOLIDATED FINANCIAL STATEMENT) LH FINANCIAL GROUP PUBLIC COMPANY LIMITED MANAGEMENT DISCUSSION AND ANALYSIS FOR THE FIRST QUARTER ENDED

(THIS REPORT DISCUSSES PRINCIPAL CHANGES ON THE REVIEWED CONSOLIDATED FINANCIAL STATEMENT) LH FINANCIAL GROUP PUBLIC COMPANY LIMITED MANAGEMENT DISCUSSION AND ANALYSIS FOR THE FIRST QUARTER ENDED 31

Management Discussion and Analysis Fiscal year ended February 28, 2022 AEON Thana Sinsap (Thailand) Public Company Limited (“the Company”) has already submitted the audited financial statements for

 positive the groups funding is from the shareholders equity. Major Factors which could have an Impact on the Company's Performance The company business is that of an electronics manufacturing service company

funding is from the shareholders equity. Major Factors which could have an Impact on the Company's Performance The company business is that of an electronics manufacturing service company. The company

Electronics PCL has the pleasure of submitting fiscal year 2017 operating results of the Company and its subsidiaries ("the Group") based on audited consolidated financial statements for the period ended